Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $16.1 million.

  • Maxcyte's Total Current Liabilities fell 862.04% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year decrease of 862.04%. This contributed to the annual value of $15.8 million for FY2024, which is 1164.94% down from last year.
  • As of Q3 2025, Maxcyte's Total Current Liabilities stood at $16.1 million, which was down 862.04% from $11.6 million recorded in Q2 2025.
  • In the past 5 years, Maxcyte's Total Current Liabilities ranged from a high of $18.1 million in Q2 2022 and a low of $11.6 million during Q2 2025
  • For the 5-year period, Maxcyte's Total Current Liabilities averaged around $15.0 million, with its median value being $15.6 million (2021).
  • Per our database at Business Quant, Maxcyte's Total Current Liabilities skyrocketed by 4446.28% in 2022 and then tumbled by 2707.51% in 2023.
  • Quarter analysis of 5 years shows Maxcyte's Total Current Liabilities stood at $15.6 million in 2021, then dropped by 1.22% to $15.4 million in 2022, then increased by 15.74% to $17.9 million in 2023, then dropped by 11.65% to $15.8 million in 2024, then grew by 2.07% to $16.1 million in 2025.
  • Its last three reported values are $16.1 million in Q3 2025, $11.6 million for Q2 2025, and $12.7 million during Q1 2025.